Skip to content

PHARMEINSA: what changed

Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.

What changed

PHARMEINSA

BE 0787.352.463
NACE 47.730, Retail sale of pharmaceutical products
financial year 2024 against 2025filed annual accounts (NBB)
Net result for the year
€146,188
2024 · €184,325-€38,137
Equity
€5,042
2024 · €470,853-€465,812
Cash
€527,185
2024 · €380,267+€146,919
Balance sheet total
€757,173
2024 · €631,096+€126,078

Largest movements

2024 to 2025
Assets
  • Cash +€146,919

    up €146,919 (+38.6%), from €380,267 to €527,185

    mainly Other debts (+€518,653) and Net result for the year (+€146,188)

  • Tangible fixed assets -€15,294

    down €15,294 (-18.6%), from €82,101 to €66,808

    of which Furniture and vehicles: -€18,632

Equity and liabilities
  • Other debts +€518,653

    new in 2025: €518,653

  • Profit (loss) carried forward -€465,812

    down €465,812 (-100.0%), from €465,853 to €42

  • Tax, wage and social debts +€92,289

    up €92,289 (+132.0%), from €69,920 to €162,210

    of which Taxes: +€93,952

  • Trade debts -€19,053

    down €19,053 (-21.1%), from €90,322 to €71,269

Income statement
  • Gross operating margin -€65,235

    down €65,235 (-20.9%), from €312,562 to €247,327

  • Staff costs -€13,611

    down €13,611 (-30.7%), from €44,371 to €30,760

  • Taxes -€12,214

    down €12,214 (-21.9%), from €55,792 to €43,578

  • Financial charges -€4,828

    down €4,828 (-94.0%), from €5,134 to €306

From the 2024 result to the 2025 result

effect on the result

Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.

Result 2024 €184,325
Gross operating margin -€65,235
Staff costs +€13,611
Depreciation -€1,739
Other operating charges +€471
Financial income -€2,287
Financial charges +€4,828
Taxes +€12,214
Result 2025 €146,188

Cash bridge derived

cash 2024 to 2025

Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.

From operations +€766,650
Investment -€7,731
Financing -€612,000
Cash 2024 €380,267
Net result for the year +€146,188
Depreciation +€23,024
Stocks and contracts -€2,116
Receivables within one year +€6,679
Deferred charges and accrued income +€985
Trade debts -€19,053
Tax, wage and social debts +€92,289
Other debts +€518,653
Investment in fixed assets (net) -€7,731
Contributions, distributions and other -€612,000
Cash 2025 €527,185
Every line side by side 40 lines
Line Code 2024 2025 Change %
Total assets 20/58 €631,096 €757,173 +€126,078 +20.0%
Fixed assets 21/28 €89,151 €73,858 -€15,294 -17.2%
Tangible fixed assets 22/27 €82,101 €66,808 -€15,294 -18.6%
Furniture and vehicles 24 €70,872 €52,241 -€18,632 -26.3%
Other tangible fixed assets 26 €11,229 €14,567 +€3,338 +29.7%
Financial fixed assets 28 €7,050 €7,050 = 0.0%
Current assets 29/58 €541,945 €683,316 +€141,371 +26.1%
Stocks and contracts in progress 3 €90,143 €92,259 +€2,116 +2.3%
Stocks 30/36 €90,143 €92,259 +€2,116 +2.3%
Amounts receivable within one year 40/41 €63,058 €56,379 -€6,679 -10.6%
Trade receivables 40 €63,058 €56,379 -€6,679 -10.6%
Current investments 50/53 €0 - =
Cash at bank and in hand 54/58 €380,267 €527,185 +€146,919 +38.6%
Deferred charges and accrued income 490/1 €8,477 €7,492 -€985 -11.6%
Total equity and liabilities 10/49 €631,096 €757,173 +€126,078 +20.0%
Equity 10/15 €470,853 €5,042 -€465,812 -98.9%
Contributions 10/11 €5,000 €5,000 = 0.0%
Profit (loss) carried forward 14 €465,853 €42 -€465,812 -100.0%
Amounts payable 17/49 €160,243 €752,132 +€591,889 +369.4%
Amounts payable within one year 42/48 €160,243 €752,132 +€591,889 +369.4%
Current portion of amounts payable after more than one year 42 €0 - =
Trade debts 44 €90,322 €71,269 -€19,053 -21.1%
Suppliers 440/4 €90,322 €71,269 -€19,053 -21.1%
Taxes, remuneration and social security 45 €69,920 €162,210 +€92,289 +132.0%
Taxes 450/3 €64,362 €158,314 +€93,952 +146.0%
Remuneration and social security 454/9 €5,558 €3,896 -€1,662 -29.9%
Other amounts payable 47/48 - €518,653 +€518,653
Remuneration, social security and pensions 62 €44,371 €30,760 -€13,611 -30.7%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €21,286 €23,024 +€1,739 +8.2%
Other operating charges 640/8 €3,970 €3,499 -€471 -11.9%
Gross operating margin 9900 €312,562 €247,327 -€65,235 -20.9%
Operating profit (loss) 9901 €242,935 €190,043 -€52,892 -21.8%
Financial income 75/76B €2,316 €29 -€2,287 -98.7%
Recurring financial income 75 €2,316 €29 -€2,287 -98.7%
Financial charges 65/66B €5,134 €306 -€4,828 -94.0%
Recurring financial charges 65 €5,134 €306 -€4,828 -94.0%
Profit (loss) for the period before taxes 9903 €240,117 €189,766 -€50,351 -21.0%
Income taxes 67/77 €55,792 €43,578 -€12,214 -21.9%
Profit (loss) for the period 9904 €184,325 €146,188 -€38,137 -20.7%
Profit (loss) for the period to be appropriated 9905 €184,325 €146,188 -€38,137 -20.7%

Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 9 October 2026 via checked.be.